Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its SmartSpeed artificial intelligence (AI) powered MR acceleration software has received U.S. Food and Drug Administration (FDA) 510(k) clearance.
Adding advanced AI data collection algorithms to Philips’ existing Compressed SENSE MR acceleration engine, Philips
SmartSpeed delivers higher image resolution with 3 times faster scan times  and virtually no loss in image quality, representing a major step forward in diagnostic confidence and MR department productivity.
With personalized treatment for complex diseases such as cancer increasing the need for high-confidence precision diagnoses, coupled with soaring caseloads due to aging populations and high levels of clinician burnout, radiology departments are under increasing pressure to improve performance, productivity, and profitability.
“Philips’ AI-based SmartSpeed reconstruction is the new benchmark among acceleration techniques for us. It improves on the company’s existing Compressed SENSE in all aspects and allows a reduction in scan times with excellent image quality and diagnostic confidence,” said Dr. Grischa Bratke, radiologist and expert in musculoskeletal imaging at the University Hospital of Cologne, Cologne, Germany.
Philips SmartSpeed, the latest addition to Philips’ expanding portfolio of AI-driven, smart, connected imaging and smart workflow solutions, helps achieve the Quadruple Aim of improving diagnostic outcomes, enhancing patient and staff experiences, and reducing healthcare costs overall.
This latest AI-powered MR software increases resolution up to 65% and achieves up to 3 times faster scanning times compared to conventional MR scans .
Coupled with its support for 97% of current clinical protocols  – including advanced contrasts and diffusion weighted imaging, and even quantitative imaging such at T1 or T2 mapping for brain, liver, heart or musculoskeletal (MSK) imaging – Philips SmartSpeed helps increase diagnostic confidence in a wide range of patients, including the most complex cases.
The unique deep learning technology of Philips SmartSpeed is applied at the source of the MR signal and seamlessly integrated with Philips leading Compressed SENSE speed engine to deliver higher resolution and high signal-to-noise ratio needed for detailed images, small lesion detection and enhanced diagnosis.